Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Pathology
|
September 22, 2010
The senescence pathway in prostatic carcinogenesis
Sowmya Sharma, Joo-Shik Shin, Matthew Grimshaw, et al.
Aging
|
December 17, 2013
Age-associated stresses induce an anti-inflammatory senescent phenotype in endothelial cells
Paul R Coleman, Garry Chang, Gabor Hutas, et al.
Blood
|
July 29, 2010
Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells
Paul R Coleman, Christopher N Hahn, Matthew Grimshaw, et al.
Future Oncology (London, England)
|
January 30, 2026
JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC
Lillian L Siu, Barbara Burtness, Kevin Harrington, et al.
Gynecologic Oncology
|
May 29, 2026
Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial
Matthew A Powell, Henrik Roed, Lyndsay J Willmott, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2025
A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel
Matthew A Powell, Line Bjørge, Lyndsay Willmott, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Pathology
|
September 22, 2010
The senescence pathway in prostatic carcinogenesis
Sowmya Sharma, Joo-Shik Shin, Matthew Grimshaw, et al.
Aging
|
December 17, 2013
Age-associated stresses induce an anti-inflammatory senescent phenotype in endothelial cells
Paul R Coleman, Garry Chang, Gabor Hutas, et al.
Blood
|
July 29, 2010
Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells
Paul R Coleman, Christopher N Hahn, Matthew Grimshaw, et al.
Future Oncology (London, England)
|
January 30, 2026
JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC
Lillian L Siu, Barbara Burtness, Kevin Harrington, et al.
Gynecologic Oncology
|
May 29, 2026
Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial
Matthew A Powell, Henrik Roed, Lyndsay J Willmott, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2025
A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel
Matthew A Powell, Line Bjørge, Lyndsay Willmott, et al.
Page
of 1